Currently, some of the tools used in HCC diagnosis are the costly computed tomography (CT) scan, ultrasound (US), magnetic resonance imaging (MRI) as well as the blood biomarkers such as Alpha fetoprotein (AFP) [6]. This evidence concerns the gene AFP and hepatocellular carcinoma.